Lee Hambright
Stock Analyst at Bernstein
(1.82)
# 1,924
Out of 4,433 analysts
9
Total ratings
90%
Success rate
17.18%
Average return
Main Sectors:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Outperform | $350 → $365 | $398.82 | -8.48% | 2 | May 31, 2023 | |
| MDT Medtronic | Maintains: Outperform | $100 → $99 | $85.92 | +15.22% | 1 | May 26, 2023 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $136 → $152 | $120.18 | +26.48% | 1 | May 3, 2023 | |
| ABT Abbott Laboratories | Maintains: Outperform | $125 → $132 | $104.09 | +26.81% | 1 | Jan 26, 2023 | |
| DXCM DexCom | Initiates: Outperform | $105 | $131.36 | -20.07% | 1 | Jul 15, 2022 | |
| JNJ Johnson & Johnson | Downgrades: Market Perform | $183 | $154.64 | +18.34% | 1 | Mar 16, 2022 | |
| SYK Stryker | Upgrades: Outperform | $288 → $295 | $334.68 | -11.86% | 1 | Mar 16, 2022 | |
| EW Edwards Lifesciences | Upgrades: Outperform | $132 → $135 | $89.14 | +51.45% | 1 | Mar 16, 2022 |
Intuitive Surgical
May 31, 2023
Maintains: Outperform
Price Target: $350 → $365
Current: $398.82
Upside: -8.48%
Medtronic
May 26, 2023
Maintains: Outperform
Price Target: $100 → $99
Current: $85.92
Upside: +15.22%
Zimmer Biomet Holdings
May 3, 2023
Maintains: Market Perform
Price Target: $136 → $152
Current: $120.18
Upside: +26.48%
Abbott Laboratories
Jan 26, 2023
Maintains: Outperform
Price Target: $125 → $132
Current: $104.09
Upside: +26.81%
DexCom
Jul 15, 2022
Initiates: Outperform
Price Target: $105
Current: $131.36
Upside: -20.07%
Johnson & Johnson
Mar 16, 2022
Downgrades: Market Perform
Price Target: $183
Current: $154.64
Upside: +18.34%
Stryker
Mar 16, 2022
Upgrades: Outperform
Price Target: $288 → $295
Current: $334.68
Upside: -11.86%
Edwards Lifesciences
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $89.14
Upside: +51.45%